Drug research has advanced in remarkable ways, but it’s still about the basics: ensuring safety, efficacy and compliance. That trio is no easy feat, but without a strong clinical strategy, even the most promising, safe and compliant drug can fail. Get your research in better strategic shape with this quick-start plan.
September 30, 2020
Flow Cytometry User Groups And The Relaunch Of The NWFCS
By Jennifer J. Stewart, PhD
Live Dead Measurement and Cell Viability
By Marrisssa Bailey, BS
To Fc or not Fc: An assay for the question
By Shalina Prasad BS
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
